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MEDICAL BOARD OF CALIFORNIA 
Executive Director, Kimberly Kirchmeyer: (916) 263-2389 ♦ License Verification, General 
Licensing, Application and Complaint Information (Toll-Free): 1-800-633-2322 ♦ Website: 
www.mbc.ca.gov 
 
Protection of the public shall be the highest priority for the Medical Board of 
California in exercising its licensing, regulatory, and disciplinary functions. 
Whenever the protection of the public is inconsistent with other interests 
sought to be promoted, the protection of the public shall be paramount. 
 
— Business and Professions Code § 2000.1 
 
he Medical Board of California (MBC) is a consumer protection agency within 
the state Department of Consumer Affairs (DCA). The primary purpose of 
MBC is to protect consumers from incompetent, grossly negligent, unlicensed, 
impaired, or unethical practitioners by responding to complaints from the public and reports from 
health care facilities and other mandated reporters. MBC reviews the quality of medical practice 
carried out by physicians and surgeons and enforces the disciplinary, administrative, criminal, and 
civil provisions of the Medical Practice Act, Business and Professions Code section 2000 et seq. 
MBC also provides public record information about physicians to the public via its website and 
individual requests and educates healing arts licensees and the public on health quality issues. The 
Board’s regulations are codified in Division 13, Title 16 of the California Code of Regulations 
(CCR).  
MBC is responsible for ensuring that all physicians licensed in California have adequate 
medical education and training. In this regard, the Board issues regular and probationary licenses 
and certificates under its jurisdiction, administers a continuing medical education program, and 
administers physician and surgeon examinations to some license applicants. MBC also oversees 
the regulation of licensed midwives; polysomnographic technologists, technicians, and trainees; 
research psychoanalysts; and medical assistants.  
T 
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The fifteen-member Board consists of eight physicians and seven public members. MBC 
members are appointed by the Governor (who appoints all eight physicians and five public 
members), the Speaker of the Assembly (one public member), and the Senate Rules Committee 
(one public member). Members serve a four-year term and are eligible for reappointment to a 
second term. Several standing committees and ad hoc task forces assist the Board. 
The Senate Rules Committee appointed Eserick “TJ” Watkins as a public member of MBC 
on June 1, 2019. He previously served as a Board member on the Physical Therapy Board of 
California. Mr. Watkins is the owner of The Next Level Coaching, a hybrid strength training and 
life coaching company, and holds a Master of Business Administration (MBA). 
On June 3, 2019, Governor Newsom appointed Asif Mahmood, M.D., an internal medicine 
and pulmonary disease specialist at Huntington Memorial Hospital in Pasadena since 2000. He 
was chief of staff at the Greater El Monte Hospital from 2011 to 2012.  
On July 26, 2019, Governor Newsom appointed Alejandra Casillas, M.D., an assistant 
professor of medicine and primary care physician at the UCLA School of Medicine since 2016. 
Casillas earned both a Doctor of Medicine degree and a Master of Science degree from the UCLA 
School of Public Health.  
On July 26, 2019, Governor Newsom appointed Richard Thorp, M.D., president and chief 
executive officer at Paradise Medical Group since 2001. Thorp is an internal medicine physician 
and a member of the American Medical Association, American College of Physicians, California 
Medical Association, and the Butte-Glenn County Medical Association. 
Also, on July 26, 2019, Governor Newsom reappointed Dev GnanaDev, M.D., to MBC, 
where he has served since 2011. GnanaDev has been chairman of the Department of Surgery at 
Arrowhead Regional Medical Center since 1989, a clinical professor of surgery at the Western 
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University of Health Sciences since 1995, and an associate professor of surgery at Loma Linda 
University since 1993. He is a member of the California Medical Association, the American 
Medical Association, the Society for Vascular Surgery, and the American College of Surgeons.  
On October 8, 2019, Governor Newsom announced the appointment of MBC’s Executive 
Director Kimberly Kirchmeyer as Director of the California Department of Consumer Affairs. 
Kirchmeyer has been executive director of the Medical Board of California since 2013, and 
previously served as deputy director of MBC from 2011 to 2013. Ms. Kirchmeyer’s new 
appointment leaves a vacancy at MBC that the Board will fill with an interim executive director at 
its November 2019 meeting. 
At this writing, the Board has two vacancies—one physician and one public member—
which must be filled by Governor Gavin Newsom.  
MAJOR PROJECTS 
Revised Licensure Application Questions 
At its May 9, 2019 meeting, the Board considered revising its licensure application 
questions pertaining to applicant mental health. MBC’s licensure and registration applications 
currently require applicants to disclose whether they have, at any time, received a diagnosis for an 
emotional, mental, behavioral, addictive, neurological, or other physical disorder or condition that 
impairs their ability to practice medicine safely. In April 2018, the Federation of State Medical 
Boards (FSMB), after researching physician wellness and burnout, published recommendations 
for state medical boards regarding revisions to certain questions on applications for licensure and 
registration. Specifically, FSMB recommended that state medical boards consider revising or 
excluding application questions concerning an applicant’s mental health or substance abuse 
histories if those questions are worded in such a way as to discourage physicians seeking treatment 
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from disclosing pertinent information. According to FSMB, application questions should not give 
the appearance to physicians seeking treatment that disclosing the information is meant to be 
punitive instead of beneficial. To ensure compliance with the Americans with Disabilities Act 
(ADA), FSMB also recommended that application questions focus on an applicant’s ongoing 
impairments and not on other previous impairments, illnesses, diagnoses, or treatment. At its 
January 2019 meeting, Board members shared concerns with the revised application questions and 
directed staff to work with a committee appointed to take up the issue and report back in May. 
[24:2 CRLR 46–47] 
At the May meeting, Executive Director Kirchmeyer shared that a Task Force made up of 
Ms. Pines and Dr. Lewis explored the matter, reviewed other states’ applications as well as other 
California boards’ applications, and made recommendations that are incorporated into the 
revisions. Ms. Kirchmeyer explained that the updates intend to eliminate open and unlimited 
questions and still ensure the Board can perform its role of consumer protection. After some 
discussion, the Board voted unanimously to approve the changes to the application as 
recommended.  
Patient’s Right to Know Act 
On July 1, 2019, The Patient’s Right to Know Act of 2018, SB 1448 (Chapter 570, Statutes 
of 2018), took effect. It requires physicians who have been placed on probation for certain offenses 
to notify their patients of their probationary status. Cases may involve the commission of any 
sexual abuse, misconduct, or relations with a patient or client as defined in Business and 
Professions Code sections 726 or 729; drug or alcohol abuse directly resulting in harm to patients 
or to the extent that such use impairs the ability of the licensee to practice safely; criminal 
convictions involving harm to patient health; or inappropriate prescribing resulting in harm to 
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patients and a probationary period of five years or more. According to MBC President Pines, in 
the Summer 2019 Newsletter, the new law is explained to help patients make informed decisions 
about their physicians, thus boosting “consumer empowerment.” The bill arose from a legislative 
oversight hearing on June 18, 2018, to examine health practitioner discipline and provide 
Committee members information about existing requirements and potential loopholes in the law. 
[24:1 CRLR 51–52, 56–57] 
Consolidation of Postgraduate Training Regulations  
At its August 9, 2019 meeting [Agenda item 24], MBC staff provided an update on two 
overlapping rulemaking packages—Approved Postgraduate Training and New Postgraduate 
Training Requirements, sections 1320 and 1321, Title 16 of the CCR—and clarified the rationale 
to combine the packages into one. Staff explained that the initial rulemaking made amendments to 
allow the Board to give credit to applicants who went to postgraduate training programs accredited 
by the American Osteopathic Association (AOA) that had reached initial or pre-accreditation 
status with the Accreditation Council of Graduate Medical Education (ACGME). Staff noted that 
AOA had confirmed that allopathic physicians are not going into these postgraduate training 
programs until they are fully accredited by ACGME. Therefore, since this is not an issue, that 
provision will be removed from the rulemaking packet. Staff shared additional clarifying changes 
that will bring sections 1320 and 1321 up to date with legislative changes. Specifically, section 
1320 is changed to allow a longer, thirty-nine-month exemption period for postgraduate training. 
Staff further explained that in section 1321, the Board clarified that postgraduate training programs 
located in the United States, its territories, and Canada that are accredited by the accreditors the 
Board relies on would be approved. 
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Additionally, Staff explained changes that updated the statutory authorizations based on 
the Board’s new postgraduate training requirements. MBC originally published notice of its intent 
to amend section 1321 on January 25, 2019. [24:2 CRLR 43–44] 
The Board voted unanimously to direct staff to submit the newly revised proposed 
regulations to the DCA for approval; once approved, to submit the regulations to OAL for formal 
notice, and to authorize staff to make any non-substantive changes to the language and respond to 
non-substantive comments during the rulemaking process without returning the matter to the 
Board. As of this writing, the New Postgraduate Training Requirements rulemaking package is 
pending initial DCA review and has not yet been formally noticed. 
Recommended Withdrawal of Pending Rulemaking on 
Supervision Required for Physician Assistants 
On October 15, 2019, MBC staff drafted a report to share at the November Board meeting 
[Agenda item 22] with a recommendation to withdraw the pending rulemaking on supervision 
requirements for Physician Assistants (PAs). Existing law under section 1399.545, Title 16 of the 
CCR, sets forth the supervising mechanisms for PAs, in which the supervising physician must 
review, countersign, and date a sample consisting of, at a minimum, five percent of the medical 
records of patients treated by the PA functioning under adopted protocols within 30 days of the 
date of treatment by the PA. The regulation also requires the supervising physician to select for 
review those cases that, by diagnosis, problem, treatment, or procedure, represent, in his or her 
judgment, the most significant risk to the patient.  
At its January 18, 2018, board meeting, MBC approved proposed changes to section 
1399.545 to update this regulation based on legislative changes. Board staff prepared the 
rulemaking file, which progressed through the review, notice, and hearing process. On October 9, 
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2019, however, the Governor signed SB 697 (Caballero) (Chapter 707, Statutes of 2019), which 
significantly changes the law regarding PA supervision (see LEGISLATION). Consequently, the 
proposed rulemaking on section 1399.545 will be outdated and inconsistent with the law as of 
January 1, 2020. For this reason, staff will recommend MBC withdraw the proposed rulemaking 
at its November Board meeting.  
Opioid Safety Efforts 
In its Spring Newsletter, MBC provided an update on efforts to fight opioid addiction. 
Addiction, misuse, and overdose of prescription opioids is a public health crisis in California, and 
throughout the U.S., that affects both adults and children. On January 1, 2019, legislation took 
effect, SB 1109 (Bates) (Chapter 693, Statutes of 2018), that utilizes a multi-pronged educational 
approach: teaching providers, patients, student-athletes and their parents about the potential 
hazards associated with prescribing and taking opioids. As it relates to doctors, the new law 
requires pain management continuing education courses that include the risks of addiction 
associated with the use of Schedule II drugs; and requires that prescribers discuss addiction and 
overdose associated with opioids with a minor and the minor’s parent or guardian before 
dispensing or writing the first prescription of an opioid. The MBC website regularly posts alerts 
from the California Department of Public Health Statewide Opioid Safety (SOS) workgroup with 
guidance for prescribers, first-responders, and clinicians on how to address issues related to their 
practice. 
LEGISLATION 
SB 786 (Senate Committee on Business, Professions, and Economic Development), as 
amended September 5, 2019, repeals Article 11 (commencing with section 2200) of the Business 
and Professions Code. This provision authorized MBC to award loans, in specified circumstances, 
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to licensed physicians and surgeons who agree to establish a medical practice in an area deficient 
in primary care services and required those loans to be repayable to the Contingent Fund of the 
MBC. SB 786 repeals these provisions in their entirety because the programs are no longer 
operational.  
Governor Gavin Newsom signed SB 786 on October 2, 2019 (Chapter 456, Statutes of 
2019). 
AB 241 (Kamlager-Dove), as amended August 28, 2019, and as it applies to MBC, 
amends section 2190.1 of the Business and Professions Code to require continuing education 
courses for physicians and surgeons to include the understanding of implicit bias and the 
promotion of bias-reducing strategies. The bill makes legislative findings and declarations as to 
the prevalence of implicit bias in the medical field. Among other things, the legislature found that 
implicit bias contributes to the unequal treatment of patients based on immutable characteristics, 
including race, ethnicity, gender identity, and sexual orientation. Further, unequal treatment of 
certain patients by licensees leads to health disparities in these vulnerable populations, even when 
controlling for other factors. [24:2 CRLR 49] Specifically, amended section 2190.1 requires MBC 
to adopt regulations by January 1, 2022, to adopt an implicit bias curriculum, as specified in the 
bill. 
Governor Gavin Newsom signed AB 241 on October 2, 2019 (Chapter 417, Statutes of 
2019). 
AB 845 (Maienschein), as amended April 1, 2019, adds section 2196.9 to the Business 
and Professions Code to require MBC to consider including a course in maternal mental health 
when determining its continuing education requirements for doctors and to make periodic updates 
to any course curricula with new research findings on maternal mental health. Effective July 1, 
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2019, providers are required to screen pregnant and postpartum women for maternal mental health 
conditions. Effective January 1, 2020, the law also requires specified hospitals to develop and 
implement programs relating to postpartum depression and other maternal mental health 
conditions. According to the bill’s author, in light of the prevalence of maternal mental health 
disorders as the most common complication of giving birth, health care providers need training to 
identify and treat them appropriately. As the new screening mandate under AB 2193 
(Maienschein) (Chapter 755, Statutes of 2018) took effect on July 1, 2019, it is imperative that 
providers who treat mothers during the perinatal period are fully supported and empowered to 
deliver quality care. 
Governor Gavin Newsom signed AB 845 on September 4, 2019 (Chapter 220, Statutes of 
2019). 
SB 425 (Hill), as amended September 5, 2019, amends sections 2221 and 2234 of the 
Business and Professions Code to require MBC to disclose probationary certificates and the 
statement of issues to an interested member of the public, and to post these documents on MBC’s 
website for ten years from the date of issuance. Also, amended section 2234 removes the condition 
that failure to attend and participate in an investigation-related interview with MBC, without good 
cause, be repeated before rising to the level of “unprofessional conduct” disciplinable by MBC. 
SB 425 arises out of a hearing held in 2018 by the Senate Committee on Business, Professions and 
Economic Development (Sexual Misconduct Reporting in the Medical Profession: Missed 
Opportunities to Protect Patients), that explored whether licensed health professionals who fail to 
meet established standards are discovered, reviewed and disciplined, if necessary, in a timely 
manner. MBC voted unanimously to support the bill at its May 9 meeting. The Board believes the 
bill will help prevent delays in the Board’s enforcement process and increase transparency by 
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providing access to information that is public, but not available on MBC’s website after a 
probationary period is complete. [24:2 CRLR 50] 
Governor Gavin Newsom signed SB 425 on October 12, 2019 (Chapter 849, Statutes of 
2019). 
AB 1264 (Petrie-Norris), as amended June 25, 2019, amends section 2242 of the Business 
and Professions Code to clarify that, for purposes of this section, the requirement to perform an 
“appropriate prior examination” before prescribing, dispensing, or furnishing self-administered 
hormonal contraceptives does not require real-time interaction between the patient and the 
licensee. Instead, the examination can be achieved through the use of telehealth, including, but not 
limited to, a self-screening tool or a questionnaire, provided that the licensee complies with the 
appropriate standard of care. The bill includes an urgency clause and became effective 
immediately upon signature. 
Governor Gavin Newsom signed AB 1264 on October 11, 2019 (Chapter 741, Statutes of 
2019). 
SB 377 (McGuire), as amended September 6, 2019, amends sections 369.5 and 739.5 of 
the Welfare and Institutions Code to, upon approval by a juvenile court judicial officer of a request 
for authorization for the administration of psychotropic medication to a juvenile patient, require 
the officer to authorize MBC to review the patient’s medical record. Amended section 369.5 limits 
review of the juvenile patient’s medical record to the diagnosis for the authorized prescription of 
psychotropic medication, so MBC can determine whether excessive prescribing inconsistent with 
the standard of care is occurring. According to the author, “SB 377 will cut through this red tape 
and allow MBC to carry out their oversight authority.” [24:2 CRLR 51] MBC voted to support the 
bill at its May 9 meeting. 
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Governor Gavin Newsom signed SB 377 on October 7, 2019 (Chapter 547, Statutes of 
2019). 
AB 528 (Low), as amended September 6, 2019, amends section 209 of the Business and 
Professions Code, and amends, repeals, and add sections 11164.1, 11165, 11165.1, and 11165.4 
of the Health and Safety Code relating to controlled substances. The bill states the legislature’s 
intent to use prescription drug monitoring programs to continue to empower healthcare-oriented 
technology solutions to the opioid crisis. The bill changes the timeframe for dispensers to report 
dispensed prescriptions to the Controlled Substance Utilization Review and Evaluation System 
(CURES) from seven days to the following working day; authorizes physicians licensed by the 
MBC but who do not hold a federal Drug Enforcement Agency Registration to register for access 
to CURES; requires pharmacists to report Schedule V controlled substances to CURES; expands 
authority for a prescriber’s licensed delegate to retrieve data from CURES on behalf of that 
prescriber; and makes other clarifying and technical changes to a prescriber’s duty to consult 
CURES. According to the bill’s author, reducing the time a pharmacist has to report to CURES 
from 7 days to one working day prevents “doctor shoppers” from visiting multiple prescribers over 
the course of a whole week to obtain multiple prescriptions.  
After a discussion at its August 8 meeting about potential impacts on workflow and 
auditing, MBC voted to support AB 528 if section 11165.4 was amended to remove the exemption 
that a covering physician would not have to check CURES. This change was made in the final 
language of the bill. Sections 11164.1 and 11165 will become operative January 1, 2021. Sections 
11165.1 and 11165.4 will become operative on July 1, 2021, or upon the date the department 
promulgates regulations to implement this section and posts those regulations on its internet 
website, whichever date is earlier. 
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Governor Gavin Newsom signed AB 528 on October 9, 2019 (Chapter 677, Statutes of 
2019). 
AB 714 (Wood), as amended June 17, 2019, amends sections 740 and 741 of the Business 
and Professions Code, to clarify when naloxone must be offered and under what circumstances. 
This bill is in response to AB 2760 (Wood) (Chapter 324, Statutes of 2018) and clarifies the 
existing requirement for a prescriber to offer naloxone or other FDA approved drug for the 
complete or partial reversal of opioid-induced respiratory depression only when the prescriber is 
prescribing an opioid or benzodiazepine and one or more at-risk conditions are present. The bill 
further exempts patients in inpatient facilities and hospice care from AB 2760 requirements. The 
bill includes an urgency clause and became effective immediately upon signature. 
Governor Gavin Newsom signed AB 714 on September 5, 2019 (Chapter 231, Statutes of 
2019). 
AB 1519 (Low) (the sunset bill for the Dental Board of California), as amended September 
6, 2019, amends section 2096 of the Business and Professions Code relating to the Medical Board 
of California. The bill specifies that oral and maxillofacial surgery residency programs accredited 
by American Dental Association Commission on Dental Accreditation (CODA) shall be approved 
as postgraduate training required for licensure if the applicant attended the program as part of the 
combined dental and medical degree program accredited by CODA. The bill specifies that these 
programs do not have to comply with the requirement that postgraduate training must include four 
months of general medicine.  
Governor Gavin Newsom signed AB 1519 on October 13, 2019 (Chapter 865, Statutes of 
2019). 
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SB 159 (Wiener), as amended September 5, 2019, amends section 4052 of, and adds 
sections 4052.02 and 4052.03 to, the Business and Professions Code relating to HIV prevention. 
The bill authorizes a pharmacist to furnish a 60-day supply of preexposure prophylaxis (PrEP) or 
post-exposure prophylaxis (PEP) if certain conditions are met, including that the pharmacist 
determines the patient meets the clinical criteria for PrEP or PEP consistent with federal guidelines. 
According to the bill’s author, currently, PrEP and PEP require a physician’s prescription, which 
delays or prevents some people from accessing the drugs that can significantly reduce the risk of 
HIV-infection in adults at high risk. The bill requires a pharmacist, before furnishing PrEP or PEP, 
to complete a training program approved by the Board of Pharmacy in consultation with MBC. 
The bill further requires the Board of Pharmacy, in consultation with MBC, to adopt emergency 
regulations by July 1, 2020, to implement the bill’s requirements in accordance with the Center 
for Disease Control guidelines.  
At its August 8 meeting, MBC members discussed possible impacts of the bill. Some Board 
members emphasized that they support the bill because it broadens individual access to these 
potentially life-saving drugs. Other Board members expressed concern about pharmacists’ 
workflow and lack of monitoring of patients by physicians if the bill passes.  
Despite the Board’s lack of support, Governor Gavin Newsom signed SB 159 on October 
7, 2019 (Chapter 532, Statutes of 2019). 
SB 697 (Caballero), as amended September 3, 2019, amends various provisions of the 
Business and Professions Code, relating to physician assistants (PAs). The bill revises the 
Physician Practice Act to allow multiple physicians and surgeons to supervise a PA, replaces the 
delegation of service agreement with a practice agreement, and eliminates the existing medical 
records review requirement. According to the bill’s sponsor, the California Academy of PAs, 
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statutory limitations on case reviews and the single physician supervision model is overly 
burdensome and duplicative of other protections built into the healthcare system. To reduce those 
duplicative requirements, this bill eliminates the statutory requirements for administrative 
oversight by physicians. It instead requires physicians and PAs to determine for themselves the 
appropriate level of supervision, with every licensee involved in a specific practice agreement 
subject to discipline for improper supervision. MBC voted to support SB 697 at its August meeting. 
Governor Gavin Newsom signed SB 697 on October 9, 2019 (Chapter 707, Statutes of 
2019). 
SB 276 (Pan), as amended July 1, 2019, amends sections 120370, 120375, and 120440 of, 
and adds sections 120372 and 120372.05 to, the Health and Safety Code, to address concerns with 
the issuance and oversight of medical exemptions provided by physicians to pupils seeking to 
forego immunization requirements to attend schools. This bill addresses circumstances created 
with the passage of SB 277 (Pan) (Chapter 35, Statutes of 2015), which eliminated the personal 
belief exemption from the requirement that children receive specified vaccines for certain 
infectious diseases prior to being admitted to any private or public elementary or secondary school, 
or daycare center, as specified. SB 277 waived the immunization requirement if a pupil’s parent 
or guardian filed a medical exemption, which is a written statement by a licensed physician to the 
effect that immunization is not considered safe for that child, indicating the specific nature and 
probable duration of their medical condition or circumstances. Since 2015, the number of 
physician-issued medical exemptions more than tripled. Many of the exemptions are clustered in 
the same schools, creating concentrated pockets of unvaccinated individuals.  
SB 276 requires the state’s Department of Public Health (DPH), by January 1, 2021, to 
develop and make available an electronic, standardized, and statewide certified form for physicians 
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to use with pupils whose parents have requested a medical exemption to the required immunization 
requirements in order to gain admission to school. The form will be transmitted directly to DPH’s 
existing California Immunization Registry (CAIR). Beginning January 1, 2021, the bill requires 
clinically trained staff members at DPH to annually review immunization reports from all schools 
and institutions, especially those with immunization rates of less than 95% and exemptions from 
physicians who submit five or more in a calendar year. The bill permits DPH to deny or revoke a 
medical exemption determined to be inappropriate or invalid.  
As it relates to MBC, the bill specifies that if DPH determines a physician’s practice 
contributes to a public health risk, DPH shall report the physician to MBC or the Osteopathic 
Medical Board of California, as appropriate. The bill establishes an appeals process for medical 
exemptions that are denied or revoked and creates an independent review panel made up of three 
physicians for appeal purposes. The bill requires the exemption form to include an authorization 
to release medical records to DPH, MBC, and Osteopathic Medical Board of California. This will 
remove the obstacle the Board is currently facing in investigating medical exemption cases. 
At a May 28 board meeting via teleconference, and again, at its August 8 board meeting, 
MBC allowed extensive public comment both for and against the bill. After deliberation, MBC 
members voted in support of SB 276. 
Governor Gavin Newsom signed SB 276 on September 9, 2019 (Chapter 278, Statutes of 
2019). 
AB 744 (Aguilar-Curry), as amended September 10, 2019, amends section 2290.5 of the 
Business and Professions Code, and amends section 1374.13 of, and adds section 1374.14 to, the 
Health and Safety Code. This bill requires a health plan or insurer to reimburse for services 
provided through telehealth on the same basis and to the same extent that the health plan or insurer 
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is responsible for reimbursement for the same service through in-person diagnosis, consultation, 
or treatment. The bill’s sponsor, the California Medical Association, argues the bill will reduce 
barriers to the provision of and payment for telehealth services, thus, increasing access to care. 
Governor Gavin Newsom signed AB 744 on October 13, 2019 (Chapter 867, Statutes of 
2019). 
Legislative Bills That Died 
The following bills reported in Volume 24, No. 2 (Spring 2019) are still pending in 
committee: AB 387 (Gabriel), which would require physicians and surgeons to advise patients as 
to the purpose of a prescribed drug or device upon the prescription of said drug or device, and 
permit patients to opt out of having the purpose of a prescribed drug or device included by the 
covered prescriber on the prescription label; AB 1030 (Calderon and Petrie-Norris), which would 
require MBC, in coordination with the American College of Obstetricians and Gynecologists, to 
develop an informational pamphlet for patients undergoing gynecological exams that contains 
certain information, such as what pelvic exams and pap smears are, how doctors perform them, 
and patient privacy expectations; SB 201 (Wiener), which would, in the absence of medical 
necessity and the subsequent informed consent of the parent(s) or guardian(s), forbid licensees 
from performing any treatment or intervention on the sex characteristics of an intersex minor 
without the informed consent thereof; AB 544 (Brough), which would limit the maximum inactive 
license renewal fee to, at most, fifty percent of the renewal fee for active licenses and would also 
prohibit MBC from requiring payment of outstanding accrued renewal fees as a condition for 
reinstatement of an expired license or registration; AB 370 (Voepel), which would limit the amount 
that licensees may charge patients for filling out certain medical and related forms to a reasonable 
fee based on the actual time and cost for filling out the form. 
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LITIGATION 
Kennedy v. Grafilo, Case No. CPF19516531 (Super. Ct. San Francisco) 36 Cal. App. 
5th 306 (2019). This matter stems from a series of investigative subpoenas MBC served on Dr. 
Ron Kennedy, seeking the medical records of three minors for whom Dr. Kennedy provided 
vaccination exemptions. After Dr. Kennedy refused to produce the records, the Director of DCA 
filed a petition in the superior court, compelling him to comply with the subpoenas. The superior 
court granted the petition and ordered Dr. Kennedy to produce records shortly thereafter. The 
superior court denied Dr. Kennedy’s request to stay the order while he pursued appellate review. 
Dr. Kennedy then filed the instant petition for a writ of supersedeas to stay the order pending 
appeal. The trial court denied Dr. Kennedy’s request to stay the order while he pursued appellate 
review. 
The appellate court held that the automatic stay provisions sought by petitioner Dr. 
Kennedy do not apply to a special proceeding. The appellate court’s conclusion is consistent with 
the practice of federal courts, where appellants are not entitled to an automatic stay pending appeal 
of a subpoena compliance order. Following legal precedent, the appellate court reasoned that an 
automatic stay would impede the Board’s discharge of its duty to protect the public against 
incompetent, impaired, or negligent physicians since the Legislature has “broadly” vested the 
Board with authority to investigate complaints against physicians. Thus, the appellate court denied 
the petitioner’s request for a writ of supersedeas to stay the superior court’s order compelling him 
to produce patient records for the MBC. The court also declined to grant a discretionary stay of 
the order. 
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RECENT MEETINGS 
At its August 9 meeting, MBC unanimously elected public member Denise Pines as 
President, licensee member Dr. Ronald Lewis as Vice President, and licensee member Dr. Howard 
Krauss as Secretary. The Board also appointed Dr. Dev GnanaDev to the Health Professions and 
Education Foundation. 
At the August 9 meeting, Dr. Hawkins provided an update on the Stem Cell and 
Regenerative Therapy Task Force [Agenda item 21]. He gave an overview of the creation of the 
Task Force and its purpose to evaluate the prevalence, promotional practices, and incidences of 
patient harm related to regenerative medicine and adult stem cell therapies in the U.S. and to 
identify and report recommended best regulatory practices and guidelines. Dr. Hawkins shared 
that Board staff met with officials from the state’s Department of Public Health to discuss 
collaboration, potential legislation, and investigating complaints regarding these practices. Dr. 
Krauss added that Task Force members met with Board staff in June 2019 to discuss oversight 
options and next steps to protect California consumers. Dr. Krauss announced the interested parties 
meeting that occurred on September 18, 2019. 
At the August meeting, Board staff presented an update on several rulemaking packages in 
process or still pending DCA review: Physician and Surgeon Health and Wellness Program [23:2 
CRLR 50–51]; Notice to Consumers [24:1 CRLR 54–55]; New Postgraduate Training 
Requirements [24:2 CRLR 43–44]; Approved Medical Assistant Certifying Organizations [24:2 
CRLR 42–43]; and Substantial Relationship and Rehabilitation Criteria (Agenda item 18) 
discussed at May 10, 2019 Board meeting. At this writing, the Board has not formally noticed any 
of these proposed regulations.  
